Altimmune ALT
NASDAQ ALT
$2.73 -0.03 (-1.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

Altimmune (ALT) Net Preferred Shares Issued and Repurchased (2016 - 2017)

Updated

Altimmune's Net Preferred Shares Issued and Repurchased was $13.02 million in FY2017, up 129.5% from $5.67 million in FY2016.

Analysis

Altimmune (ALT) Net Preferred Shares Issued and Repurchased (2016 - 2017) Analysis & Trends

  • Per Business Quant data, Net Preferred Shares Issued and Repurchased in earlier years was $5.67 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Altimmune 530.91 Mn 530.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 12.97 Mn
Sep 30, 2016 2.00 Mn
API Access

Altimmune Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=ALT&period=max&api_key=YOUR_API_KEY